|
Sign In to gain access to subscriptions and/or personal tools.
|
Journal of Oncology Pharmacy Practice, Vol. 12, No. 3,
155-164 (2006)
DOI: 10.1177/1078155206070774
Fatigue in cancer patients treated with cytotoxic drugs
Per Hartvig, PharmD, PhD
Hospital Pharmacy, University Hospital, Uppsala, Sweden
Johan Aulin, MSc in pharmacy
Hospital Pharmacy, University Hospital, Uppsala, Department of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden
Matilda Hugerth, MSc in pharmacy
Department of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden
Sofia Wallenberg, MSc in pharmacy
Department of Pharmacokinetics and Drug Therapy, Uppsala University, Uppsala, Sweden
Gunnar Wagenius, MD, PhD
Department of Oncology, University Hospital, Uppsala, Sweden
Study objectives. Cancer-related fatigue is a significant and distressing problem for the cancer patient, affecting their physical and psychosocial function negatively, and reducing their quality of life. The aims of this study were to assess frequency, severity, and the consequence of fatigue in cancer outpatients receiving cytotoxic drugs, using an existing international fatigue scale applied for Swedish use.
Methods. The study used a non-randomized, prospective design to evaluate fatigue and its impact on quality of life in outpatients receiving cytotoxic drugs. Once a week, 147 cancer patients, in an outpatient ward for cytotoxic drug administration, filled out questionnaires containing 13 items from the Fatigue Symptom Inventory (FSI), and five additional questions.
Results. Prevalence of fatigue was 92% in the week after all patients had received cytotoxic drugs, and patients were statistically significantly more fatigued during than before treatment. The degree of fatigue was highest the week after treatment, and declined over the following week. Other symptoms, especially depressed mood, showed a strong correlation with cancer and cytotoxic-induced fatigue. Lung and breast cancer patients experienced the highest degree of fatigue. Some cytotoxic drug regimens were, apart from the underlying disease, associated with high fatigue scores, eg, those with cyclophosphamide or gemcitabine. Patients not receiving first line treatment scored significantly higher fatigue with more influence on daily living.
Conclusion. The study verified that fatigue is a common side effect, and affects quality of life negatively, even for outpatients receiving cytotoxic drugs. The clinical oncology pharmacist must inform patients that a severe tiredness, fatigue, may follow cytotoxic drug administration.
Key Words: cytotoxic drugs fatigue quality of life self-report side effects
References
- Patrick DL, Ferketich SL, Frame PS, et al. National Institutes of Health State-of-the-Science Conference Statement: symptom management in cancer: pain, depression, and fatigue, July 15-17, 2002 . J Nat Cancer Inst 2003; 95: 1110-1117 .[Abstract/Free Full Text]
- Simon A, Zittoun R. Fatigue in cancer patients . Curr Opin Oncol 1999; 11: 244-249 .[CrossRef][Medline]
[Order article via Infotrieve]
- Ream E, Richardson A. From therapy to practice: designing interventions to reduce fatigue in patients with cancer . Oncol Nurs Forum 1999; 26: 1295-1303 .[Medline]
[Order article via Infotrieve]
- Irvine D, Vincent L, Graydon J, et al. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy drugs and radiotherapy . Cancer Nurs 1994; 17: 367-378 .[Medline]
[Order article via Infotrieve]
- Kalman D. Nutritional aspects of cancer-related fatigue . J Am Diet Assoc 1997; 97: 650-654 .[CrossRef][Medline]
[Order article via Infotrieve]
- Rhodes V, Watson PM, Hanson BM. Patients description of the influence of tiredness and weakness on self-care abilities . Cancer Nurs 1988; 11: 186-194 .[Medline]
[Order article via Infotrieve]
- Aistars J. Fatigue in the cancer patient: a conceptual approach to a clinical problem . Oncol Nurs Forum 1987; 14: 25-29 .[Medline]
[Order article via Infotrieve]
- Dimeo F, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and psychological status of cancer patients during cytotoxic drugs . Cancer 1999; 85: 2273-2277 .[CrossRef][Medline]
[Order article via Infotrieve]
- Richardson A. Measuring fatigue in patients with cancer . Support Care Cancer 1998; 6: 94-100 .[CrossRef][Medline]
[Order article via Infotrieve]
- Piper B, Lindsey AM, Dodd M. Fatigue mechanisms in cancer patients: developing nursing theory . Oncol Nurs Forum 1987; 14: 17-23 .[Medline]
[Order article via Infotrieve]
- Richardson A. Fatigue in cancer patients: a review of the literature . Eur J Cancer Care 1995; 4: 20-32 .
- Hartvig P, Aulin J, Wallenberg S, et al. Physical exercise for cytotoxic drug induced fatigue . J Oncol Pharm Pract (submitted 10.1177/1078155206070766).
- Hann D, Jacobsen PB, Azzarello LM. Measurement of fatigue in cancer patients: development and validation of the fatigue symptom inventory . Qual Life Res 1998; 7: 301-310 .[Medline]
[Order article via Infotrieve]
- Schwartz A, Nail LM, Chen S, et al. Fatigue patterns observed in patients receiving chemotherapy drugs and radiotherapy . Cancer Invest 2000; 18: 11-19 .[Medline]
[Order article via Infotrieve]
- Piper B. Fatigue and cancer: inevitable companions? Support Care Cancer 1993; 1: 285-286 .[CrossRef][Medline]
[Order article via Infotrieve]
- Cella D, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue . Oncology 1998; 12: 369-377 .
- Ream E, Richardson A. Fatigue: a concept analysis . Int J Nurs Stud 1996; 33: 519-529 .[CrossRef][Medline]
[Order article via Infotrieve]
- Rhoten D. Fatigue and the postsurgical patient, In Norris C ed. Concept clarification in nursing. Aspen , 1982: 277-300.
- Krupp L, LaRocca NG, Muir-Nash J, et al. The Fatigue Severity Scale . Arch Neurol 1989; 46: 1121-1123 .[Abstract]
- Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale . J Psych Res 1992; 37: 147-153 .
- Glaus A. Fatigue in patients with cancer. Analysis and assessment. Recent results . Cancer Res 1998; 145: I-XI, 1-172 .
- Kogi K, Saito Y, Mitsuhashi T. Validity of three components of subjective fatigue feelings . J Sci Lab 1970; 46: 251-270 .
- Yellen S, Cella DF, Webster K, et al. Measuring fatigue and other anaemia-related symptoms with the functional assessment of cancer therapy . J Pain Symptom Manage 1997; 13: 63-74 .[CrossRef][Medline]
[Order article via Infotrieve]
- Smets E, Garssen B, Bonke B, et al. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue . J Psych Res 1995; 39: 315-325 .
- Stein K, Martin SC, Hann DM, et al. A multidimensional measure of fatigue for use with cancer patients . Cancer Pract 1998; 6: 143-152 .[CrossRef][Medline]
[Order article via Infotrieve]
- Piper BF. Piper fatigue scale for clinical testing . Oncol Nurs Forum 1990; 17: 661-662 .[Medline]
[Order article via Infotrieve]
- Piper B, Dibble SL, Dodd MJ, et al. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer . Oncol Nurs Forum 1998: 25: 677-684 .[Medline]
[Order article via Infotrieve]
- Schwartz A. The Schwartz cancer fatigue scale: testing reliability and validity . Oncol Nurs Forum 1998; 25: 711-717 .[Medline]
[Order article via Infotrieve]
- Richardson A. The experience of fatigue and other symptoms in patients receiving chemotherapy . Eur J Cancer Care 1996; 5: 24-30 .
- Richardson A, Ream E, Wilson-Barnett J. Fatigue in patients receiving chemotherapy: patterns of change . Cancer Nurs 1998; 21: 17-30 .[Medline]
[Order article via Infotrieve]
- Smets E, Garssen B, Cull A, et al. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy . Br J Cancer 1996; 73: 241-245 .[Medline]
[Order article via Infotrieve]
- Jacobsen P, Hann DM, Azzarello LM, et al. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course and correlates . J Pain Symptom Manage 1999; 18: 233-242 .[CrossRef][Medline]
[Order article via Infotrieve]

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. C. Higgins, G. H. Montgomery, G. Raptis, and D. H. Bovbjerg
Effect of Pretreatment Distress on Daily Fatigue After Chemotherapy for Breast Cancer
J. Oncol. Pract,
March 1, 2008;
4(2):
59 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hartvig, J. Aulin, S. Wallenberg, and G. Wagenius
Physical exercise for cytotoxic drug-induced fatigue
Journal of Oncology Pharmacy Practice,
December 1, 2006;
12(4):
183 - 191.
[Abstract]
[PDF]
|
 |
|
|